|

Nivolumab + chemotherapy Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1

Top Sponsors

  • Fudan University1
  • Bristol-Myers Squibb1

Indications

  • Cancer2
  • Resectable Stage II-IIIa Squamous NSCLC1
  • Esophageal Adenocarcinoma (EAC)1
  • Gastro-esophageal Junction Adenocarcinoma1
  • Gastric Adenocarcinoma1

Other2 trials

Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC
Phase 2
Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.